Pharmabiz10m
PTC Therapeutics’ phase 2 CardinALS study of utreloxastat in ALS patients fails to meet primary endpoint
PTC Therapeutics’ phase 2 CardinALS study of utreloxastat in ALS patients fails to meet primary endpoint: Warren, New Jersey Thursday, November 28, 2024, 15:00 Hrs [IST] PTC The ...
Pharmabiz25m
Fedo.ai with Electronic Village to empower health benchmarking across the GCC Region
Fedo.ai with Electronic Village to empower health benchmarking across the GCC Region: Our Bureau, Bengaluru Thursday, November 28, 2024, 14:45 Hrs [IST] Fedo.ai, an AI-driven plat ...
Pharmabiz40m
National Epilepsy Day celebrated by Epilepsy Foundation of India and the Mumbai Educational Trust
National Epilepsy Day celebrated by Epilepsy Foundation of India and the Mumbai Educational Trust: Our Bureau, Mumbai Thursday, November 28, 2024, 14:30 Hrs [IST] In a significant ...
Pharmabiz56m
Abbott launches 14 valent pneumococcal conjugate vaccine with broad protection for children
Abbott launches 14 valent pneumococcal conjugate vaccine with broad protection for children: Our Bureau, Bengaluru Thursday, November 28, 2024, 14:15 Hrs [IST] Abbott has launched ...
Pharmabiz1h
India’s pharma’s 79% CXOs see AI/ML as key drivers of growth: EY Parthenon–OPPI report
EY Parthenon–OPPI report: Our Bureau, Bengaluru Thursday, November 28, 2024, 13:45 Hrs [IST] EY Parthenon (EY-P ...
Pharmabiz1h
Idorsia enters into exclusive negotiations with an undisclosed party for global rights to aprocitentan
Idorsia enters into exclusive negotiations with an undisclosed party for global rights to aprocitentan: Allschwil, Switzerland Thursday, November 28, 2024, 14:00 Hrs [IST] Idorsia ...
Pharmabiz1h
Women in Pharma Roundtable discusses needs and challenges of women in the sector
Women in Pharma Roundtable discusses needs and challenges of women in the sector: Our Bureau, New Delhi Thursday, November 28, 2024, 13:30 Hrs [IST] CPHI & PMEC India 2024 held a ...
Pharmabiz2h
International Pathogen Surveillance Network announces first recipients of grants to better understand disease threats
International Pathogen Surveillance Network announces first recipients of grants to better understand disease threats: Geneva Thursday, November 28, 2024, 13:00 Hrs [IST] The Worl ...
Pharmabiz2h
Dr Reddy's launches toripalimab in India for the treatment of nasopharyngeal carcinoma
Dr Reddy's launches toripalimab in India for the treatment of nasopharyngeal carcinoma: Our Bureau, Bengaluru Thursday, November 28, 2024, 12:15 Hrs [IST] Dr Reddy’s Laboratorie ...
Pharmabiz2h
CAHO & Orchid Pharma to continue supporting national efforts to check antimicrobial resistance
CAHO & Orchid Pharma to continue supporting national efforts to check antimicrobial resistance: Our Bureau, Bengaluru Thursday, November 28, 2024, 12:30 Hrs [IST] Orchid Pharma an ...
Pharmabiz3h
Lexicon completes patient enrollment in phase 2B PROGRESS study of LX9211 in diabetic peripheral neuropathic pain
Lexicon completes patient enrollment in phase 2B PROGRESS study of LX9211 in diabetic peripheral neuropathic pain: The Woodlands, Texas Thursday, November 28, 2024, 12:00 Hrs [IST ...
Pharmabiz3h
Biocon Biologics supports Diabetes Africa to drive progress in embedding specialist nurses in Ethiopia
Biocon Biologics supports Diabetes Africa to drive progress in embedding specialist nurses in Ethiopia: Our Bureau, Bengaluru Thursday, November 28, 2024, 11:40 Hrs [IST] Biocon B ...